Extended validation of a decision tool (DAPT score) in patients randomized to 6 or 12 months dual antiplatelet therapy after percutaneous coronary intervention with predominantly second-generation drug-eluting stents

被引：3
|
作者：
Harada, Yukinori [1 ]
Lohaus, Raphaela [2 ]
Mayer, Katharina [2 ]
Emmer, Roberto [2 ]
Michel, Jonathan [3 ]
Colleran, Roisin [1 ]
Giacoppo, Daniele [1 ]
Wiebe, Jens [1 ]
Byrne, Robert [1 ]
Kastrati, Adnan [2 ]
Schulz-Schuepke, Stefanie [2 ]
机构：
[1] Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany
[2] Deutsch Herzzentrum Munich, Munich, Germany
[3] Deutsch Herzzentrum Munich, Munich, Germany
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 68卷 / 18期
关键词：
D O I：
10.1016/j.jacc.2016.09.258
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-207
引用
收藏
页码：B84 / B85
页数：2
相关论文
共 50 条
  • [1] Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents
    Harada, Yukinori
    Michel, Jonathan
    Lohaus, Raphaela
    Mayers, Katharina
    Emmer, Roberto
    Lahmann, Anna Lena
    Colleran, Roisin
    Giacoppo, Daniele
    Wolk, Annabelle
    ten Berg, Jurrien M.
    Neumann, Franz-Josef
    Hans, Yaling
    Adriaenssens, Tom
    Toelg, Ralph
    Seyfarth, Melchior
    Maeng, Michael
    Zrenner, Bernhard
    Jacobshagen, Claudius
    Wohrle, Jochen
    Kufner, Sebastian
    Morath, Tanja
    Ibrahim, Tareq
    Bernlochner, Isabel
    Fischer, Marcus
    Schunkert, Heribert
    Laugwitz, Karl-Ludwig
    Mehilli, Julinda
    Byrnes, Robert A.
    Kastrati, Adnan
    Schulz-Schuepke, Stefanie
    [J]. THROMBOSIS AND HAEMOSTASIS, 2017, 117 (10) : 1989 - 1999
  • [2] The validation of the dual antiplatelet therapy score in East Asians receiving percutaneous coronary intervention with exclusively second generation drug-eluting stents
    Kim, Minkwan
    Park, Kyung Woo
    Lee, Hak Seung
    Ki, You-Jeong
    Kang, Jeehoon
    Kim, Chee-Hoon
    Han, Jung-Kyu
    Yang, Han-Mo
    Kang, Hyun-Jae
    Koo, Bon-Kwon
    Kim, Hyo-Soo
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 98 (03) : E332 - E341
  • [3] Long-Term Outcomes and Duration of Dual Antiplatelet Therapy After Coronary Intervention With Second-Generation Drug-Eluting Stents: The Veterans Affairs Extended DAPT Study
    Kinlay, Scott
    Young, Melissa M.
    Sherrod, Rebecca
    Gagnon, David R.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (02):
  • [4] Dual Antiplatelet Therapy Duration and Long-Term Risks of Adverse Outcomes After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents
    Kinlay, Scott
    Young, Melissa M.
    Sherrod, Rebecca J.
    Gagnon, David
    [J]. CIRCULATION, 2021, 144
  • [5] Compliance With Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Drug-Eluting Stents
    de Sa, Daniel D. Correa
    Lennon, Ryan J.
    Bresnahan, John F.
    Rihal, Charanjit S.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A371 - A371
  • [6] Shorter (≤6 months) vs. longer (≥12 months) dual antiplatelet therapy after second-generation drug-eluting stents implantation: a meta-analysis of randomized controlled trials
    Huang, He
    Li, Ya
    Sun, Meina
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2016, 18 (0A) : A54 - A62
  • [7] Duration of dual antiplatelet therapy after implantation of the first-generation and second-generation drug-eluting stents
    Yu, Xianpeng
    Chen, Fang
    He, Jiqiang
    Gao, Yuechun
    Wu, Changyan
    Luo, Yawei
    Zhang, Xiaoling
    Zhang, Yuchen
    Ren, Xuejun
    Lv, Shuzheng
    [J]. CORONARY ARTERY DISEASE, 2013, 24 (03) : 217 - 223
  • [8] The optimal duration of dual antiplatelet therapy in patients receiving percutaneous coronary intervention with drug-eluting stents
    Sheyin, O.
    Perez, X.
    Pierre-Louis, B.
    Kurian, D.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 512 - 512
  • [9] The optimal duration of dual antiplatelet therapy in patients receiving percutaneous coronary intervention with drug-eluting stents
    Sheyin, Olusegun
    Perez, Xavier
    Bredy-Pierre-Louis
    Kurian, Damian
    [J]. CARDIOLOGY JOURNAL, 2016, 23 (03) : 307 - 316
  • [10] Are at Least 12 Months of Dual Antiplatelet Therapy Needed for All Patients With Drug-Eluting Stents? All Patients With Drug-Eluting Stents Need at Least 12 Months of Dual Antiplatelet Therapy Response
    Podrid, Philip J.
    [J]. CIRCULATION, 2015, 131 (22) : 2020 - 2020
12345